The associations of hA3G and hA3B mRNA levels with HIV disease progression among HIV-infected individuals of China

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue SUPPL. 1, 2010, Pages

  Zhao, Min ^a   Geng, Wenqing ^a   Jiang, Yongjun ^a   Han, Xiaoxu ^a   Cui, Hualu ^a   Dai, Di ^a   Bao, Mingjia ^a   Pan, Ying ^a   Wang, Yating ^a   Zhang, Xiaoli ^a   Zhang, Min ^a   Qi, Guan ^a   Shang, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

HA3B; HA3F; HA3G; HIV 1; Slow progress patients

Indexed keywords

ENZYME CATALYTIC POLYPEPTIDE LIKE 3B; ENZYME CATALYTIC POLYPEPTIDE LIKE 3F; ENZYME CATALYTIC POLYPEPTIDE LIKE 3G; MESSENGER RNA; PEPTIDE DERIVATIVE; POLYPEPTIDE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4 LYMPHOCYTE COUNT; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VARIATION; HIV INFECTIONS; HUMANS; RNA, MESSENGER; VIRAL LOAD;

EID: 75749096967     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181c7d349     Document Type: Article

References (22)

1. Sheehy AM, Gaddis NC, Choi JD, et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral vif protein. Nature. 2002;418:646-650.
2. Harris RS, Bishop KN, Sheehy AM, et al. DNA deamination mediates innate immunity to retroviral infection. Cell. 2003;113:803-809.
3. Cullen BR. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J Virol. 2006;80:1067-1076.
4. Fisher AG, Ensoli B, Ivanoff L, et al. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science. 1987;237:888-893.
5. Strebel K, Daugherty D, Clouse K, et al. The HIV A' (sor) gene product is essential for virus infectivity. Nature. 1987;328:728-730.
6. Yu X, Yu Y, Liu B, et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science. 2003;302: 1056-1060.
7. Bishop KN, Holmes RK, Sheehy AM, et al. Cytidine deamination of retro-viral DNA by diverse APOBEC proteins. Curr Biol. 2004;14:1392-1396.
8. Mehle A, Strack B, Ancuta P, et al. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem. 2004;279:7792-7798.
9. Jarmuz A, Chester A, Bayliss J, et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics. 2002;79:285-296.
10. Wiegand HL, Doehle BP, Bogerd HP, et al. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 2004;23:2451-2458.
11. Doehle BP, Schäfer A, Cullen BR. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology. 2005; 339:281-288.
12. Hogan CM, Hammet SM. Host determinants in HIV infection and disease Part 1: cellular and humoral immune response. Ann Intern Med. 2001;134: 761-776.
13. Bakari M, Urassa W, Mhalu F, et al. Slow progression of HIV-1 infection in a cohort of antiretroviral näive hotel workers in Dar es Salaam, Tanzania as defined by their CD4 cell slopes. Scand J Infect Dis. 2008;40:407-413.
14. Langford SE, Ananworanich J, Cooper DA, et al. Predictors of disease progression in HIV infection: a review. AIDS Res Ther. 2007;4:11.
15. Cho SJ, Drechsler H, Burke RC, et al. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+T-cell count. J Virol. 2006;80:2069-2072.
16. Jin X, Brooks A, Chen H, et al. APOBEC3G/CEM mRNA (hA3G)levels associate inversely with human immunodeficiency virus viremia. J Virol. 2005;79:11513-11516.
17. Ulenga NK, Sarr AD, Thakore-Meloni S, et al. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F. J Infect Dis. 2008;198:486-492.
18. Baca-Regen L, Heinzinger N, Stevenson M, et al. Alpha interferon-induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes. J Virol. 1994;68:7559-7565.
19. Chen K, Huang J, Zhang C, et al. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. J Virol. 2006;80:7645-7657.
20. Stopak KS, Chiu YL, Kropp J, et al. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem. 2007;282:3539-3546.
21. Russell RA, Smith J, Barr R, et al. Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of HIV-1 Vif. J Virol. 2009;83:1992-2003.
22. Zennou V, Bieniasz PD. Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates. Virology. 2006; 349:31-40